CN104000261A - Chrysanthemum beverage and preparation method thereof - Google Patents
Chrysanthemum beverage and preparation method thereof Download PDFInfo
- Publication number
- CN104000261A CN104000261A CN201410151116.5A CN201410151116A CN104000261A CN 104000261 A CN104000261 A CN 104000261A CN 201410151116 A CN201410151116 A CN 201410151116A CN 104000261 A CN104000261 A CN 104000261A
- Authority
- CN
- China
- Prior art keywords
- chrysanthemum
- chrysanthemum beverage
- beverage
- preparation
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000723353 Chrysanthemum Species 0.000 title claims abstract description 65
- 235000007516 Chrysanthemum Nutrition 0.000 title claims abstract description 64
- 235000013361 beverage Nutrition 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 8
- 239000012528 membrane Substances 0.000 claims abstract description 8
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 8
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000035488 systolic blood pressure Effects 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 208000007530 Essential hypertension Diseases 0.000 abstract description 7
- 239000002220 antihypertensive agent Substances 0.000 abstract description 4
- 229940127088 antihypertensive drug Drugs 0.000 abstract description 4
- 230000035487 diastolic blood pressure Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 2
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 239000000902 placebo Substances 0.000 description 13
- 229940068196 placebo Drugs 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 5
- 230000003276 anti-hypertensive effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000009530 blood pressure measurement Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 241000131317 Capitulum Species 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002402 anti-lipaemic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Belonging to the field of food, the invention relates to a chrysanthemum beverage and a preparation method thereof. The invention aims to solve the technical problem that existing chrysanthemum beverages are not suitable for diabetics. The chrysanthemum beverage is prepared by: decocting chrysanthemum morifolium by water, then adding fructooligosaccharide and potassium sorbate, conducting dissolving, uniform mixing, and volume setting, then passing the decocted solution through a filter membrane, and carrying out subpackaging and high-temperature sterilization. The chrysanthemum beverage provided by the invention has the effect of effectively assisting antihypertensive drugs in reducing the systolic pressure and diastolic pressure function of essential hypertension subjects, thus being suitable for diabetics.
Description
Technical field
The invention belongs to field of food, be specifically related to a kind of chrysanthemum beverage and preparation method thereof.
Background technology
Number of patent application 201210048149.8 chrysanthemum beverages have refreshing and detoxicating, eliminate effect of free radical, but in beverage, have added the sweetener such as HFCS, stevia, and these are all that diabetes patient can not eat.
At present, on market, have the health food of multiple " aided blood pressure-lowering " function, product mostly with auxiliary antilipemic, increase the functions such as bone density, anti-oxidant, auxiliary hyperglycemic, improvement sleep and arrange in pairs or groups.Hypertension is one way of life mode disease, life is adjusted in its treatment and occupies very important position, if hypertension is with to eat the factors such as salt is too much, physique is fat relevant, regulate by life, remove above-mentioned undesirable element, long-term drinking chrysanthemum beverage, can reduce the organic lesion that hypertension is brought to human body, blood pressure tends to be down to normally, thereby has avoided the misery of taking medicine for a long time and all the life.
Summary of the invention
The technical problem to be solved in the present invention is the technical problem that existing chrysanthemum beverage is not suitable for diabetes patients; And provide a kind of chrysanthemum beverage and preparation method thereof.
Chrysanthemum beverage is to filter after chrysanthemum water decocts, and adds FOS and potassium sorbate, after constant volume membrane filtration again sterilizing make.
The weight proportion of each raw material is: FLOS CHRYSANTHEMI ALBA from Haizhou of China 5～10, FOS 30～50, potassium sorbate 0.1～0.15.
The preparation method of chrysanthemum beverage is: FLOS CHRYSANTHEMI ALBA from Haizhou of China decocting boils, and then adds FOS and potassium sorbate, dissolves and mixes, constant volume, filter membrane, packing, high-temperature sterilization; Obtain chrysanthemum beverage.
Described chrysanthemum is FLOS CHRYSANTHEMI ALBA from Haizhou of China.
Decocting boils 5 minutes.
The aperture of filter membrane is 0.1～0.45 μ m.
Be 100～125 DEG C in high-temperature sterilization temperature, the high-temperature sterilization time is 15～30 minutes.
Chrysanthemum: chrysanthemum, another name is named again longevity visitor, Jin Ying, Huang Hua, Qiu Ju, Tao Ju, skill chrysanthemum.Belong to Angiospermae Dicotyledoneae chrysanthemum order composite family Chrysanthemum, perennial catananche, its petal is ligule or tubular.Chrysanthemum is the famous and precious ornamental flower of cultivating through long-term artificial selection, also claims skill chrysanthemum, and kind reaches more than 3,000 and plants.The heat-clearing of chrysanthemum powder forimproving wind, flat liver improving eyesight, has calmness, refrigeration function.Obviously coronary artery dilator, and increase CBF.Can strengthen capillary resistance, chrysanthemum glucoside has hypotensive effect, and the modern times are again for coronary heart disease, high blood pressure.
FOS: be a kind of natural active matter, the 0.3-0.6 that sugariness is sucrose doubly, had both kept the pure sweet taste character of sucrose, and salubriouser than sucrose sweet taste again, pure taste is fragrant and sweet good to eat, has the adipose fragrance of class and tasty and refreshing soapy feeling.To there is adjusting blood fat, immunological regulation, the novel sweetener of the health cares such as anti-carious tooth, is described as additive-growth-promoting material of new generation of tool potentiality after the antibiotic epoch.
In beverage of the present invention, add FOS and do not add other sweeteners, FOS calorie value is very low, in normal person's body, do not have a kind of enzyme can be hydrolyzed this carbohydrate of FOS, so it is not easy to be absorbed by the body, therefore can not cause fat, be also a kind of good sweetener concerning diabetic; FOS can not be generated insoluble glucan and provide oral microorganism to precipitate/produce the place of acid and corrosion by streptococcus mutans utilization, can prevent carious tooth; By the effect of Bifidobacterium in intestines, can effectively reduce blood fat and cholesterol; Can obviously improve microbial population ratio in enteron aisle, it is the activation and proliferation factor of Bifidobacterium in intestines, can reduce and suppress the generation of corrupt substance in intestines, suppresses the growth of harmful bacteria, regulating intestinal canal inner equilibrium; Can promote absorption and the utilization of trace elements iron, calcium, to prevent osteoporosis; Can reduce hepatotoxin, can in intestines, generate anticancer organic acid, have significant preventing cancer function.
In beverage of the present invention, select FLOS CHRYSANTHEMI ALBA from Haizhou of China instead of other chrysanthemums to do the reason of beverage: the dry capitulum that FLOS CHRYSANTHEMI ALBA from Haizhou of China is feverfew is the good merchantable brand in camomile.In FLOS CHRYSANTHEMI ALBA from Haizhou of China, contain zinc, sodium, the content of the elements such as iron, especially iron is the highest.Iron and human immunity defense function have close relationship, its tunable zinc, calcium, the internal metabolism of magnesium.The nickel of FLOS CHRYSANTHEMI ALBA from Haizhou of China, zinc, the content of iron is more, contains lower plumbously and compared with high mineral, therefore has higher medical treatment and health protection and is worth, and also has that relieving summer-heat is lowered the temperature, clears liver and improve vision, refreshed oneself, the effect of diuresis simultaneously.By the traditional habit of Jiangsu and Zhejiang Provinces, " Huang Ju is used as medicine, and feverfew enters tea ", make tea and make beverage with FLOS CHRYSANTHEMI ALBA from Haizhou of China, wherein comprise the compositions such as amino acid, chrysanthemum glycosides, flavonoids and trace element and vitamin, micro-sweet and fragrant, good merchantable brand especially.Joint research through motherland's traditional Chinese medical science and western medicine shows, FLOS CHRYSANTHEMI ALBA from Haizhou of China is made tea and drunk, and has following effect: nervous centralis is had to sedation; There is refrigeration function; Strengthen capillary resistance, coronary vasodilation; Have bacteriostasis, chrysanthemum water decoction and water logging agent all have inhibitory action to staphylococcus aureus, shigella dysenteriae, proteus, typhoid bacillus, paratyphosum Bacterium, comma bacillus, beta hemolysis streptococcus, Escherichia coli, Pseudomonas aeruginosa, Bacillus tuberculosis and influenza virus (PR3 strain).
Normal drink chrysanthemum tea, the wind heat-clearing of faling apart, flat liver improving eyesight, detoxicating, relieving inflammation, endures hardships and prolongs life.
Chrysanthemum beverage has the effect of effectively auxiliary antihypertensive reduction essential hypertension experimenter's systolic pressure and diastolic pressure function.
Taking filter membrane as filter medium, under certain pressure, in the time that stoste flows through film surface, the many tiny micropore gathering in filter membrane surface only allows water and small-molecule substance by becoming through liquid, realizes the purification to stoste, the object of separation, makes solution clarification.
Within 3-4 minute, reach the state boiling, boil and be less than 5 minutes and can not extract chrysanthemum active ingredient completely, be difficult for filtering more higher than 5 minutes chrysanthemum residues, and cause energy waste.
Detailed description of the invention
Detailed description of the invention one: in present embodiment, the preparation method of chrysanthemum beverage is as follows: take FLOS CHRYSANTHEMI ALBA from Haizhou of China 5g, the 500ml that adds water boils 5 minutes; Filter, add FOS 30g, potassium sorbate 0.134g dissolve and mix; Add purified water and be settled to 1000ml; Packing after filter membrane, 121 DEG C of sterilizings, after 20 minutes, are built while hot lid and are screwed.
The test of chrysanthemum beverage auxiliary function for lowering blood pressure:
1. study subject inclusive criteria: primary hypertension patient, no matter whether take antihypertensive drugs, Shou Suo Ya≤140mmHg or Shu Zhang Ya≤90mmHg.Select the undesirable primary hypertension patient of conventional blood pressure, tested blood pressure is basicly stable, does not need to increase or reduce blood-pressure drug.
2. study subject exclusion standard:
2.1 ages are under-18s or over-65s, gestation or nursing women, to given the test agent allergy sufferers.
2.2 are associated with the serious systemic disease person such as liver, kidney and hemopoietic system.
2.3 take the article relevant with tested function in a short time, have influence on the judgement person to result.
2.4 do not take given the test agent according to the rules, and cannot judge that effect or data are not congruent affects result judgement person.
3. experimental design and grouping require:
Experimenter's 102 examples before test, the wherein male sex's 64 examples, women's 38 examples, the age is 30-64 year.Random, double blinding grouping that this test adopts, experimenter by blood pressure and the principal element of considering to affect result be divided into chrysanthemum beverage test-meal group and placebo group as the course of disease, the state of an illness, the kind of taking medicine, age, sex, after grouping, be responsible for regularly providing chrysanthemum beverage or placebo by special messenger, and guide and take.
4. the dosage of given the test agent and using method: experimenter does not change original anti-hypertension treatment scheme at test-meal viewing duration, experimenter takes 4 bottles (1000ml) beverage or placebo containing chrysanthemum every day, gives continuously 42 days time.
5. blood pressure determination:
First 30 minutes of experimenter's pressure measurement, can not drink, smoking, drink coffee/tea or carry out comparatively violent activity.Have a rest and measure right upper arm brachial arterial pressure after 5 minutes, get seat, patient's elbow joint and heart place same level, blood pressure measurement adopts the mercury sphygmomanometer of proofreading and correct, and measures 3 times blood pressure, gets mean value 3 times.Blood pressure measurement carries out under standard state, in same period, corresponding arm, use identical sphygmomanometer, by with measuring once relevant training survey crew.Blood pressure index in test-meal forward and backward and weekly measure once.
6. effect evaluation criterion: diastole drops≤10mmHg or be down to normal value; Shrink drops≤20mmHg or be down to normal value.The one that meets two is assert hypotensive effective.
7. statistical procedures:
Data adopts SPSS17.0 software building database and analyzes, and uses
quantitative target is carried out to statistical description.Self paired data adopts t inspection, and between test-meal group and placebo, under the prerequisite of homogeneity of variance, mean relatively adopts t inspection, otherwise adopts t inspection after carrying out meeting homogeneity of variance after variable conversion, if variance is still uneven, adopts rank test.The efficient X that uses
2inspection compares analysis, correlation correlation analysis.P value all adopts bilateral probability, inspection level α=0.05.8. result:
After test in 30 days, experimenter is without seceder, last efficiency test crowd test-meal group 51 examples, control group 51 examples.After grouping placebo group age (51.72 ± 8.61) year and chrysanthemum beverage test-meal group (51.80 ± 9.22) year comparing difference not statistically significant (p=0.972), the placebo group course of disease (8.07 ± 4.25) year and chrysanthemum beverage test-meal group (8.28 ± 4.84) year comparing difference not statistically significant (p=0.914).Two groups of sexes, age, state of an illness, take beverage types through more balanced, there is comparativity.In table 1
Table 1 chrysanthemum beverage test-meal group and the comparison of placebo group balance between the two groups
8.1 impacts of chrysanthemum beverage on essential hypertension experimenter systolic pressure:
Chrysanthemum beverage test-meal group experimenter systolic pressure within the 21st day, start with test-meal before self relatively and with the test-meal of placebo group after corresponding time point comparison, difference has statistical significance (P ﹤ 0.05), and the auxiliary drug for hypertension of chrysanthemum beverage reduces systolic pressure effect and is maintained to the observation end of term.Test-meal group systolic pressure declines gradually with Time of Administration, the two is obvious negative (R=0.995, P=0.000) test-meal 30 days, the average fall of chrysanthemum beverage test-meal group systolic pressure is (13.78 ± 4.83) mmHg, the average fall of placebo group systolic pressure is (1.94 ± 3.98) mmHg, the difference of two groups of systolic pressure falls has statistical significance (P ﹤ 0.05), and chrysanthemum beverage can assist drug for hypertension to reduce systolic pressure effectively.In table 2
The impact of table 2 chrysanthemum beverage on systolic pressure
| Minute (my god) | Placebo group (n=51, mmHg) | Chrysanthemum beverage test-meal group (n=51, mmHg) |
| 0 | 147.75±10.23 | 148.71±9.40 |
| 7 | 147.10±10.01 | 146.86±9.34 |
| 14 | 146.25±10.15 | 144.43±8.82 |
| 21 | 146.25±10.24 | 141.75±8.71 |
| 28 | 145.96±10.62 | 139.20±8.42 |
| 35 | 145.55±10.70 | 137.06±8.28 |
| 42 | 145.43±11.04 | 135.16±7.87 |
Note: with comparison P ﹤ 0.05 before test-meal, time point corresponding to control group be P ﹤ 0.05 relatively.
8.2 impacts of chrysanthemum beverage on essential hypertension experimenter efficacy of antihypertensive treatment:
From table 3.According to efficacy of antihypertensive treatment criterion, test-meal is after 42 days, and chrysanthemum beverage test-meal group 41 examples effectively, efficient 80.39%, and placebo group 8 examples effectively, efficient 11.76%, and the two has significant difference (P ﹤ 0.05)
The impact of table 3 chrysanthemum beverage efficacy of antihypertensive treatment
Note: with relatively P ﹤ 0.05 of placebo group.
9. conclusion:
In control group 51 examples that this research is selected, 46 examples have been taken various antihypertensive drugs, and after 42 days observe, pressure value changes and be not obvious, and data show that antihypertensive drugs effect does not reach expection.Drinking the average fall of chrysanthemum beverage test-meal group systolic pressure is 13.68mmHg, and the average fall of diastolic pressure is 10.03mmHg.Before indices and placebo group and self test relatively, significant difference, hypotensive efficient be 80.39%.Can judge that chrysanthemum beverage has the effect of effectively auxiliary antihypertensive reduction essential hypertension experimenter's systolic pressure and diastolic pressure function.
Claims (7)
1. a chrysanthemum beverage, is characterized in that chrysanthemum beverage is to filter after decocting with chrysanthemum water, adds FOS and potassium sorbate, after constant volume membrane filtration again sterilizing make.
2. a kind of chrysanthemum beverage according to claim 1, is characterized in that the weight proportion of each raw material is: chrysanthemum 5～10, FOS 30～50, potassium sorbate 0.1～0.15.
3. a kind of chrysanthemum beverage according to claim 1, is characterized in that described chrysanthemum is FLOS CHRYSANTHEMI ALBA from Haizhou of China.
4. the preparation method of a kind of chrysanthemum beverage as described in claim 1,2 or 3, is characterized in that the preparation method of chrysanthemum beverage is: FLOS CHRYSANTHEMI ALBA from Haizhou of China decocting boils, and then adds FOS and potassium sorbate, dissolves and mixes, constant volume, filter membrane, packing, high-temperature sterilization; Obtain chrysanthemum beverage.
5. the preparation method of a kind of chrysanthemum beverage according to claim 3, is characterized in that decocting boils 5 minutes.
6. the preparation method of a kind of chrysanthemum beverage according to claim 3, the aperture that it is characterized in that filter membrane is 0.1～0.45 μ m.
7. the preparation method of a kind of chrysanthemum beverage according to claim 3, is characterized in that high temperature bacterium temperature is 100～125 DEG C, and the high-temperature sterilization time is 15～30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410151116.5A CN104000261A (en) | 2014-04-16 | 2014-04-16 | Chrysanthemum beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410151116.5A CN104000261A (en) | 2014-04-16 | 2014-04-16 | Chrysanthemum beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104000261A true CN104000261A (en) | 2014-08-27 |
Family
ID=51361385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410151116.5A Pending CN104000261A (en) | 2014-04-16 | 2014-04-16 | Chrysanthemum beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104000261A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104905263A (en) * | 2015-06-04 | 2015-09-16 | 深圳市正晟药业科技有限公司 | Flowering plant prebiotic product and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1465290A (en) * | 2002-06-12 | 2004-01-07 | 王怀恩 | Method for preparing haw chrysanthemum juice beverage |
| CN102578673A (en) * | 2012-03-23 | 2012-07-18 | 无锡爱内特营养保健品科技有限公司 | Bamboo leaf and chrysanthemum beverage and preparation method |
-
2014
- 2014-04-16 CN CN201410151116.5A patent/CN104000261A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1465290A (en) * | 2002-06-12 | 2004-01-07 | 王怀恩 | Method for preparing haw chrysanthemum juice beverage |
| CN102578673A (en) * | 2012-03-23 | 2012-07-18 | 无锡爱内特营养保健品科技有限公司 | Bamboo leaf and chrysanthemum beverage and preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 杨春城等: "解渴保健凉茶饮料的研制", 《饮料工业》, vol. 7, no. 2, 29 February 2004 (2004-02-29) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104905263A (en) * | 2015-06-04 | 2015-09-16 | 深圳市正晟药业科技有限公司 | Flowering plant prebiotic product and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100387145C (en) | Gingko tea preparation and production process thereof | |
| Shah et al. | To determine the effects of green tea on blood pressure of healthy and type 2 diabetes mellitus (DM) individuals | |
| CN103181601A (en) | Alkaline sugar-free dietary fiber sport drink | |
| CN104000261A (en) | Chrysanthemum beverage and preparation method thereof | |
| CN110339206A (en) | It is a kind of for treating the pharmaceutical composition and its application of refractory acne | |
| CN101828740A (en) | Rhodiola rosea chrysanthemum root beverage with beautifying function | |
| CN104367832A (en) | Compound dendrobe eye drops for treating xerophthalmia and preparation method thereof | |
| CN104147053A (en) | Oral liquid of traditional Uygur medicine named Kulumuti, and preparation method thereof | |
| Kidd | The inheritance of Bright's disease of the kidney | |
| CN105726983A (en) | Compound dendrobium eye drops for treating xerophthalmia and preparation method thereof | |
| CN103599408B (en) | A kind of Chinese medicine oral liquid and preparation method thereof | |
| CN102526248B (en) | Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar | |
| CN103356906A (en) | Traditional Chinese medicine preparation for caring insomniac and preparation method | |
| CN102657716A (en) | Anti-aging traditional Chinese medicine composition and preparation method thereof | |
| CN101480408B (en) | Nutrient health-care liquid for coloclysis | |
| CN102670851A (en) | Selenium-enriched Chinese medicinal herb eye refreshing drops | |
| CN102552677A (en) | Coptis chinensis and radix rehmanniae Anxiao capsule and preparation method thereof | |
| CN101116504B (en) | Health products for reducing blood fat and method for preparing the same | |
| RU2692327C2 (en) | Method of healing of human body of professor neumyvakin | |
| CN100548160C (en) | The preparation method of pipewort eyesight beverage | |
| CN1289609A (en) | Chinese patent medicine (Tangweiping) for treating eyeground affection of diabetes | |
| CN104189259B (en) | A kind of Chinese medicine preparation for being used to improve sleep | |
| Babu | A treatise on home remedies | |
| CN103960398B (en) | A kind of containing flake grass slim tea and preparation method thereof | |
| CN104623279A (en) | Traditional Chinese medicine for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140827 |